Overview
The marketing authorisation for Coliprotec F4 has been withdrawn at the request of the marketing authorisation holder.
Coliprotec F4 : EPAR - Summary for the public
English (EN)
(415.67 KB - PDF)View
български (BG)
(339.6 KB - PDF)
español (ES)
(280.56 KB - PDF)
čeština (CS)
(323.58 KB - PDF)
dansk (DA)
(282.05 KB - PDF)
Deutsch (DE)
(283.88 KB - PDF)
eesti keel (ET)
(279.13 KB - PDF)
ελληνικά (EL)
(557.37 KB - PDF)
français (FR)
(283.25 KB - PDF)
hrvatski (HR)
(302.5 KB - PDF)
italiano (IT)
(281.12 KB - PDF)
latviešu valoda (LV)
(335.77 KB - PDF)
lietuvių kalba (LT)
(303.43 KB - PDF)
magyar (HU)
(324.05 KB - PDF)
Malti (MT)
(328.9 KB - PDF)
Nederlands (NL)
(281.07 KB - PDF)
polski (PL)
(326.11 KB - PDF)
português (PT)
(281.38 KB - PDF)
română (RO)
(302.61 KB - PDF)
slovenčina (SK)
(324.12 KB - PDF)
slovenščina (SL)
(321.83 KB - PDF)
Suomi (FI)
(279.66 KB - PDF)
svenska (SV)
(281.24 KB - PDF)
Product information
Coliprotec F4 : EPAR - Product Information
English (EN)
(707.5 KB - PDF)View
български (BG)
(1012.78 KB - PDF)
español (ES)
(820.71 KB - PDF)
čeština (CS)
(908 KB - PDF)
dansk (DA)
(826.6 KB - PDF)
Deutsch (DE)
(869.55 KB - PDF)
eesti keel (ET)
(816.49 KB - PDF)
ελληνικά (EL)
(780.33 KB - PDF)
français (FR)
(793.01 KB - PDF)
hrvatski (HR)
(769.61 KB - PDF)
íslenska (IS)
(798.87 KB - PDF)
italiano (IT)
(978.35 KB - PDF)
latviešu valoda (LV)
(931.25 KB - PDF)
lietuvių kalba (LT)
(774.14 KB - PDF)
magyar (HU)
(906.99 KB - PDF)
Malti (MT)
(925.67 KB - PDF)
Nederlands (NL)
(834.16 KB - PDF)
norsk (NO)
(716.7 KB - PDF)
polski (PL)
(905.37 KB - PDF)
português (PT)
(871.1 KB - PDF)
română (RO)
(468.63 KB - PDF)
slovenčina (SK)
(913.49 KB - PDF)
slovenščina (SL)
(1005.42 KB - PDF)
Suomi (FI)
(754.69 KB - PDF)
svenska (SV)
(824.08 KB - PDF)
Latest procedure affecting product information: R/0005
15/01/2020
Coliprotec F4 : EPAR - All Authorised presentations
English (EN)
(250.21 KB - PDF)View
български (BG)
(249.1 KB - PDF)
español (ES)
(233.3 KB - PDF)
čeština (CS)
(252.59 KB - PDF)
dansk (DA)
(225 KB - PDF)
Deutsch (DE)
(235.85 KB - PDF)
eesti keel (ET)
(233.53 KB - PDF)
ελληνικά (EL)
(255.99 KB - PDF)
français (FR)
(235.07 KB - PDF)
hrvatski (HR)
(243.63 KB - PDF)
íslenska (IS)
(251.63 KB - PDF)
italiano (IT)
(233.9 KB - PDF)
latviešu valoda (LV)
(255.18 KB - PDF)
lietuvių kalba (LT)
(251.38 KB - PDF)
magyar (HU)
(255.53 KB - PDF)
Malti (MT)
(255.1 KB - PDF)
Nederlands (NL)
(234.69 KB - PDF)
norsk (NO)
(249.14 KB - PDF)
polski (PL)
(255.19 KB - PDF)
português (PT)
(226.91 KB - PDF)
română (RO)
(245.41 KB - PDF)
slovenčina (SK)
(257.55 KB - PDF)
slovenščina (SL)
(253.51 KB - PDF)
Suomi (FI)
(234.94 KB - PDF)
svenska (SV)
(234.66 KB - PDF)
Product details
- Name of medicine
- Coliprotec F4
- Active substance
- live non-pathogenic Escherichia coli O8:K87
- International non-proprietary name (INN) or common name
- Escherichia coli, type 08, strain K87 (live)
- Species
- Pigs
- Anatomical therapeutic chemical veterinary (ATCvet) code
- QI09AE03
Pharmacotherapeutic group
- Immunologicals for suidae
- Live bacterial vaccines
- Pig
Therapeutic indication
For active immunisation of pigs against enterotoxigenic F4-positive Escherichia coli in order to:
- reduce the incidence of moderate to severe post-weaning Escherichia coli diarrhoea (PWD) in pigs;
- reduce the colonisation of the ileum and faecal shedding of enterotoxigenic F4-positive Escherichia coli from infected pigs.
Assessment history
Coliprotec F4 : EPAR - Procedural steps taken and scientific information after authorisation
English (EN)
(272.96 KB - PDF)View
Topics
This page was last updated on